Watch and wait: defining the indolent patient group in MCL
While mantle cell lymphoma (MCL) can be an aggressive disease, there is a subgroup of patients whose disease poses low risk, thus treatment may not be required. Here, Simon Rule, MD, from Plymouth Uni...
Author: VJHemOnc
Added: 09/28/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer & Oncology | Lymphoma